tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AGNPF Stock Latest News

Psychedelic: Relmada acquires neurosteroid from Asarina
The FlyPsychedelic: Relmada acquires neurosteroid from Asarina
10h ago
ATAI
CMND
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
PremiumThe Fly
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
2d ago
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
PremiumCompany Announcements
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
1M ago
Algernon Pharmaceuticals receives notice of allowance from USPTO for repirinast
PremiumThe Fly
Algernon Pharmaceuticals receives notice of allowance from USPTO for repirinast
1M ago
Algernon Pharmaceuticals Extends Warrant Expiry Date
PremiumCompany Announcements
Algernon Pharmaceuticals Extends Warrant Expiry Date
3M ago
Algernon Pharmaceuticals Secures Funding Through Private Placement
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Secures Funding Through Private Placement
6M ago
Algernon Pharmaceuticals Boosts Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Boosts Private Placement
6M ago
Algernon Pharmaceuticals Launches Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Launches Private Placement
6M ago
Algernon Pharmaceuticals Completes Key Funding Round
PremiumCompany Announcements
Algernon Pharmaceuticals Completes Key Funding Round
6M ago
Algernon Pharmaceuticals Boosts Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Boosts Private Placement
6M ago
Algernon Pharmaceuticals announces increase to private placement
PremiumThe Fly
Algernon Pharmaceuticals announces increase to private placement
6M ago
Algernon Pharmaceuticals reports results of study on ifenprodil
PremiumThe Fly
Algernon Pharmaceuticals reports results of study on ifenprodil
7M ago
Algernon Pharma Launches $250K Private Placement
PremiumCompany AnnouncementsAlgernon Pharma Launches $250K Private Placement
7M ago
Algernon Partners with ICP for Market Stability
Premium
Company Announcements
Algernon Partners with ICP for Market Stability
9M ago
Algernon Pharmaceuticals engages ICP Securities for market making services
Premium
The Fly
Algernon Pharmaceuticals engages ICP Securities for market making services
9M ago
Algernon Pharmaceuticals Unveils Stroke Study Breakthrough
PremiumCompany Announcements
Algernon Pharmaceuticals Unveils Stroke Study Breakthrough
10M ago
Algernon, CHDR to present DMT Phase 1 stroke clinical data
PremiumThe Fly
Algernon, CHDR to present DMT Phase 1 stroke clinical data
10M ago
Algernon Pharmaceuticals Unveils Future Plans
PremiumCompany Announcements
Algernon Pharmaceuticals Unveils Future Plans
10M ago
Algernon Pharmaceuticals Advances DMT Stroke Study
PremiumCompany Announcements
Algernon Pharmaceuticals Advances DMT Stroke Study
10M ago
Algernon to move forward with DMT stroke research program as lead asset
PremiumThe FlyAlgernon to move forward with DMT stroke research program as lead asset
10M ago
Algernon Sells Cough Program for $2M and Equity
Premium
Company Announcements
Algernon Sells Cough Program for $2M and Equity
11M ago
Algernon Pharmaceuticals receives notice of intention for Chinese patent
Premium
The Fly
Algernon Pharmaceuticals receives notice of intention for Chinese patent
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >